GHRS (GHRS) Stock Price & Analysis
GHRS (GHRS) fell 1.58% to USD 27.79 as of September 8, 2026 at 17:04 UTC, according to Nexqual real-time market data.
GHRS last closed at USD 27.79; the session ranged USD 27.21–28.33 on volume of 119,341 shares. Market capitalization is —, with a 52-week range of USD 11.83–31.44 (NGM). Source: Nexqual, September 8, 2026 at 17:04 UTC.
Key Statistics (as of September 8, 2026 at 17:04 UTC)
| Price | USD 27.79 |
|---|---|
| Change | ▼ 1.58% (down) |
| Previous Close | USD 27.79 |
| Open | USD 27.79 |
| Day Range | USD 27.21 – 28.33 |
| 52-Week Range | USD 11.83 – 31.44 |
| Volume | 119,341 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (GHRS)
Nexqual's technical model rates GHRS "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of September 8, 2026 at 17:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.45 (neutral) |
| vs SMA50 | Below (USD 28.16) |
| MACD | -0.09 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATAI | AtaiBeckley Inc. | USD 7.37 | ▲ 0.34% |
| GLUE | Monte Rosa Therapeutics, Inc. | USD 14.04 | ▼ 2.36% |
| HELP | Cybin Inc. | USD 12.45 | ▲ 5.73% |
| CMPS | COMPASS Pathways Plc - American | USD 14.11 | ▲ 6.17% |
| JBIO | Jade Biosciences, Inc. | USD 19.86 | ▲ 0.03% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:04 UTC. This page is informational and not investment advice.